These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22280197)

  • 21. Direct health system costs for systemic lupus erythematosus patients in Alberta, Canada.
    Fatoye F; Gebrye T; Svenson LW
    PLoS One; 2021; 16(5):e0251409. PubMed ID: 33961687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term medical costs and resource utilization in systemic lupus erythematosus and lupus nephritis: a five-year analysis of a large medicaid population.
    Li T; Carls GS; Panopalis P; Wang S; Gibson TB; Goetzel RZ
    Arthritis Rheum; 2009 Jun; 61(6):755-63. PubMed ID: 19479688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic lupus erythematosus--disease activity, severity, treatment and costs.
    Isenberg DA; Shortall E; Newman S
    J Rheumatol; 1994 Mar; 21(3):394-6. PubMed ID: 8006881
    [No Abstract]   [Full Text] [Related]  

  • 24. The economic burden of systemic lupus erythematosus in commercially- and medicaid-insured populations in the United States.
    Clarke AE; Yazdany J; Kabadi SM; Durden E; Winer I; Griffing K; Costenbader KH
    Semin Arthritis Rheum; 2020 Aug; 50(4):759-768. PubMed ID: 32531505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic lupus erythematosus.
    Manson JJ; Rahman A
    Orphanet J Rare Dis; 2006 Mar; 1():6. PubMed ID: 16722594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic lupus erythematosus and the economic perspective: a systematic literature review and points to consider.
    Turchetti G; Yazdany J; Palla I; Yelin E; Mosca M
    Clin Exp Rheumatol; 2012; 30(4 Suppl 73):S116-22. PubMed ID: 23072767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hospitalization of patients with systemic lupus erythematosus is a major cause of direct and indirect healthcare costs.
    Anandarajah AP; Luc M; Ritchlin CT
    Lupus; 2017 Jun; 26(7):756-761. PubMed ID: 27831537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-of-illness studies in systemic lupus erythematosus: A systematic review.
    Zhu TY; Tam LS; Li EK
    Arthritis Care Res (Hoboken); 2011 May; 63(5):751-60. PubMed ID: 21557530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiology and survival of systemic lupus erythematosus in Hong Kong Chinese.
    Mok CC
    Lupus; 2011 Jun; 20(7):767-71. PubMed ID: 21148605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Costs of illness and quality of life in patients with systemic lupus erythematosus in South Korea.
    Cho JH; Chang SH; Shin NH; Choi BY; Oh HJ; Yoon MJ; Lee EY; Lee EB; Lee TJ; Song YW
    Lupus; 2014 Aug; 23(9):949-57. PubMed ID: 24563501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic lupus erythematosus - an update.
    Drug and Therapeutics Bulletin
    Drug Ther Bull; 2011 Jul; 49(7):81-4. PubMed ID: 21752833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic lupus erythematosus.
    O'Neill S; Cervera R
    Best Pract Res Clin Rheumatol; 2010 Dec; 24(6):841-55. PubMed ID: 21665130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreasing costs and improving outcomes in systemic lupus erythematosus: using regression trees to develop health policy.
    Clarke AE; Bloch DA; Danoff DS; Esdaile JM
    J Rheumatol; 1994 Dec; 21(12):2246-53. PubMed ID: 7699625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Morbidity and mortality in systemic lupus erythematosus].
    Marai I; Levi Y; Shoenfeld Y
    Harefuah; 2001 Dec; 140(12):1177-80, 1229, 1228. PubMed ID: 11789304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulmonary manifestations of systemic lupus erythematosus.
    Kamen DL; Strange C
    Clin Chest Med; 2010 Sep; 31(3):479-88. PubMed ID: 20692540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Total costs and predictors of costs in patients with systemic lupus erythematosus.
    Sutcliffe N; Clarke AE; Taylor R; Frost C; Isenberg DA
    Rheumatology (Oxford); 2001 Jan; 40(1):37-47. PubMed ID: 11157140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Underestimating the value of women: assessing the indirect costs of women with systemic lupus erythematosus. Tri-Nation Study Group.
    Clarke AE; Penrod J; St Pierre Y; Petri MA; Manzi S; Isenberg DA; Gordon C; Senecal JL; Fortin PR; Sutcliffe N; Goulet JR; Choquette D; Grodzicky T; Esdaile JM
    J Rheumatol; 2000 Nov; 27(11):2597-604. PubMed ID: 11093439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychological aspects of systemic lupus erythematosus: cognitive function, mood, and self-report.
    Denburg SD; Carbotte RM; Denburg JA
    J Rheumatol; 1997 May; 24(5):998-1003. PubMed ID: 9150099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and clinicopathologic findings of antiphospholipid syndrome nephropathy in Thai systemic lupus erythematosus patients who underwent renal biopsies.
    Cheunsuchon B; Rungkaew P; Chawanasuntorapoj R; Pattaragarn A; Parichatikanond P
    Nephrology (Carlton); 2007 Oct; 12(5):474-80. PubMed ID: 17803471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How does one assess and monitor patients with systemic lupus erythematosus in daily clinical practice?
    Haq I; Isenberg DA
    Best Pract Res Clin Rheumatol; 2002 Apr; 16(2):181-94. PubMed ID: 12041948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.